Spark Investment Management LLC Corvus Pharmaceuticals, Inc. Transaction History

Spark Investment Management LLC

  • $17.4 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019
SELL
$3.29 - $8.94 $80,605 - $219,030
-24,500 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$8.58 - $11.4 $76,362 - $101,460
8,900 Added 57.05%
24,500 $210,000
Q2 2018

Aug 08, 2018
BUY
$9.42 - $13.73 $45,216 - $65,904
4,800 Added 44.44%
15,600 $171,000
Q1 2018

May 10, 2018
SELL
$7.48 - $11.53 $132,396 - $204,081
-17,700 Reduced 62.11%
10,800 $124,000
Q4 2017

Feb 12, 2018
BUY
$9.3 - $16.93 $265,050 - $482,505
28,500
28,500 $295,000

Others Institutions Holding CRVS

# of Institutions
73
Shares Held
30.4M
Call Options Held
1.06M
Put Options Held
84.3K
View Full List

About Corvus Pharmaceuticals, Inc.

CRVS Quotes by TradingView
  • Ticker CRVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,553,500
  • Market Cap $223M
  • Description
  • Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...
More about CRVS
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email